Summary

Report Summary

OpenEvidence, Inc. Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of OpenEvidence, Inc. 's business operations. It provides a detailed analysis of the company's strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.

The report begins with in-depth information about OpenEvidence, Inc. including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.

Next, the report assesses OpenEvidence, Inc.'s strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. By integrating these strategic analyses, the report offers a comprehensive understanding of OpenEvidence, Inc.'s overall strategic standing and supports informed decision-making and strategic planning.

Finally, the report includes recent news and deal activities undertaken by OpenEvidence, Inc. enhancing awareness of the company's business trends, growth perspectives, and more.

Key Highlights

OpenEvidence Inc is an American artificial intelligence and healthcare technology company founded in 2021 that develops a specialized medical information and clinical decision support platform for healthcare professionals. Initially launched from the Mayo Clinic Platform Accelerate program and co-founded by entrepreneur Daniel Nadler and AI researcher Zachary Ziegler, OpenEvidence is headquartered in Cambridge, Massachusetts, United States and also maintains significant operations linked to Miami, Florida. The company was created to tackle the problem of overwhelming medical research volume by aggregating, organizing, and synthesizing peer reviewed medical knowledge so that physicians and clinicians can make faster evidence-based decisions at the point of care. OpenEvidence’s core business segment is its clinical decision support and medical search platform, an AI-driven application designed to help doctors, nurses, and other healthcare professionals easily access up-to-date citations and summaries from leading clinical journals such as The New England Journal of Medicine and the JAMA Network. The platform uses state-of-the-art natural language processing and large language models to provide real-time answers grounded in medical literature, helping clinicians quickly evaluate evidence and improve patient outcomes. Users must be verified healthcare professionals to access the service, which is widely used across tens of thousands of hospitals and care centers in the United States and increasingly abroad

OpenEvidence, Inc. in the News:-

2026-02-25 - OpenEvidence wide-releases AI-integrated Doctor Dialer, for privacy-centric, doctor-patient telemedicine with clinical decision AI deeply integrated
2026-01-20 - 45 Rwandan Clinicians Are Helping Shape Medical AI for Low-Resource Settings
2025-12-16 - OpenEvidence Expands Access to AAFP’s Evidence-Based Family Medicine Guidance at the Point of Care
2025-12-04 - OpenEvidence HIPAA-secure Dialer now available
2025-11-08 - American College of Cardiology, OpenEvidence to Advance AI-Enabled, Evidence-Based Cardiovascular Care


Scope

• Tactical Analysis:- Various strategic frameworks to gain insights into a company's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
• Business Strategy:- Contributes to shaping the company's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
• Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
• Competitive Landscape:- An identification of the company's main competitors, providing insights into the competitive landscape it operates in.

Reasons to Buy

• Comprehensive Understanding of the OpenEvidence, Inc.'s internal and external factors through SWOT analysis and Corporate Strategy.
• Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
• Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
• Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
• Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.

Additionally, available deep-dive analysis on the company OpenEvidence, Inc.:

• OpenEvidence, Inc. PESTLE Analysis
• OpenEvidence, Inc. Value Chain Analysis
• OpenEvidence, Inc. Porter's Five Forces Analysis
• OpenEvidence, Inc. VRIO Analysis
• OpenEvidence, Inc. BCG Analysis
• OpenEvidence, Inc. Segmentation, Targeting and Positioning (STP) Analysis
• OpenEvidence, Inc. Ansoff Matrix Analysis

ページTOPに戻る

Table of Contents

Tables 5
Charts 6
OpenEvidence, Inc. - Key Company Facts 7
OpenEvidence, Inc. - Company Description 8
OpenEvidence, Inc. - Top Executives 9
OpenEvidence, Inc. - Head Office & Locations 10
Head Office - Country 10
OpenEvidence, Inc. - Products and Services 11
Products 11
Services 12
OpenEvidence, Inc. - Corporate Strategy 13
OpenEvidence, Inc. - Business Description 16
Clinical Decision Support and Medical Information Platform 16
OpenEvidence, Inc. - ESG Spotlight 18
Environment 18
Social 19
Corporate Governance 20
OpenEvidence, Inc. - SWOT Analysis 21
Overview 21
Strengths 23
Weaknesses 26
Opportunities 28
Threats 30
Competing Players 33
Snapshot of Competing Players 34
Wolters Kluwer N.V 34
Key Company Facts 34
Company Description 34
Key Financials 35
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 35
Key Financial Ratio Analysis 40
Doximity Inc 42
Key Company Facts 42
Company Description 42
Key Financials 43
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 43
Key Financial Ratio Analysis 48
Abridge AI Inc 50
Key Company Facts 50
Company Description 50
OpenEvidence, Inc. - In the News 51
25-Feb-2026- OpenEvidence wide-releases AI-integrated Doctor Dialer, for privacy-centric, doctor-patient telemedicine with clinical decision AI deeply integrated 51
20-Jan-2026- 45 Rwandan Clinicians Are Helping Shape Medical AI for Low-Resource Settings 52
16-Dec-2025- OpenEvidence Expands Access to AAFP’s Evidence-Based Family Medicine Guidance at the Point of Care 53
04-Dec-2025- OpenEvidence HIPAA-secure Dialer now available 54
08-Nov-2025- American College of Cardiology, OpenEvidence to Advance AI-Enabled, Evidence-Based Cardiovascular Care 54
16-Oct-2025- OpenEvidence and Veeva Announce Long Term Partnership 56
21-Aug-2025- OpenEvidence Launches “Visits” 56
15-Aug-2025- OpenEvidence Creates the First AI in History to Score a Perfect 100% on the United States Medical Licensing Examination (USMLE) 57
09-Jul-2025- New Feature Upload and Analyze Text-Based Documents Directly in OpenEvidence Conversations 58
29-Apr-2025- Mayo Clinic study: OpenEvidence performs comparably to physician CDM in common clinical scenarios 58
OpenEvidence, Inc. - Key Deals 59
11-Feb-2026 - Sutter Health Collaborates with OpenEvidence to Bring Evidence-Based, AI-Powered Insights into Physician Workflows 59
11-Dec-2025 - ACEP and OpenEvidence Partner to Expand Access to Emergency Medicine Resources 60
05-Nov-2025 - NCCN and OpenEvidence Collaborate to Bring Clinical Oncology Guidelines to Medical AI 60
Appendix 62
Definitions 62
SWOT Analysis 62
PESTLE Analysis 62
Value Chain Analysis 62
ESG Spotlight 62
Research Methodology 63
Disclaimer 64
Contact Us 64